ArticlePloS one2022

HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling.

Huiling Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.